Raymond James sets USD 150.00 target for Encompass Health stock

Published on 10/17/2026 at 18:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue rose 9.60 percent year over year. On NYSE, Encompass Health stock was last at USD 127.87 on October 16, 2026, down 0.08 percent.

Analyst target and key dates

Raymond James set a USD 150.00 target on September 28, 2026, 17.30 percent above the price.
Second-quarter revenue rose 9.60 percent year over year to USD 1.60 billion.
Encompass Health stock was last at USD 127.87 at 4:00 p.m. ET on October 16, 2026, down 0.08 percent on the NYSE.
Encompass Health will report third-quarter results after the market close on October 28, 2026.

EHC, US29261A1007, Illustration mit AI erstellt.

Encompass Health Corporation (ISIN US29261A1007) had a USD 150.00 price target from Raymond James dated September 28, 2026, according to MarketBeat. Against the last NYSE quote, that target was 17.30 percent higher. Encompass Health was last at USD 127.87 on October 16, 2026 at 4:00 p.m. ET on the NYSE, down 0.08 percent from the previous session.

Revenue growth reached 9.60 percent

Encompass Health reported second-quarter 2026 revenue of USD 1.60 billion, up 9.60 percent from the same quarter a year earlier, according to Yahoo Finance. The report also put adjusted earnings per share at USD 1.55, above the USD 1.48 consensus estimate. The revenue comparison gives the target price a fundamental backdrop, but the next report will provide the next major update.

Stock stays near its yearly high

The USD 92.77 to USD 129.96 52-week range was current on October 16, 2026. At USD 127.87 on that date, Encompass Health stood 1.61 percent below the high. Trading volume reached 1,289,662 shares, compared with an average of 902,956 shares.

Valuation and October 28 results

Encompass Health had a market capitalization of USD 12.6 billion and a P/E ratio of 20.83 as of October 16, 2026. The company announced on October 1, 2026 that it will report third-quarter results after the market close on October 28, 2026, according to Encompass Health. The earnings call is scheduled for October 29, 2026 at 10:00 a.m. ET.

Comparison with peers

Encompass Health (NYSE, USD): minus 0.08 percent, P/E 20.83, market capitalization USD 12.6 billion.

HCA (NYSE, USD): minus 2.06 percent, P/E 15.36, market capitalization USD 99.3 billion.

Universal Health Services (NYSE, USD): minus 1.21 percent, P/E 7.59, market capitalization USD 10.9 billion.

Price and next date

The latest home-exchange quote was USD 127.87 on October 16, 2026 at 4:00 p.m. ET on the NYSE, down 0.08 percent from the previous session. The next scheduled company event is the third-quarter results release after the market close on October 28, 2026.